Life Sciences Update | 2022 October

Contents

Following extraordinary investment, expansion, and innovation in 2021, the life sciences industry is poised for further growth and consistent demand in the years ahead. Going forward, capitalising on the latest trends in technology will be more critical than ever as these advancements are continuously reshaping the way we research, develop, test, go to market and analyse data in life sciences. Even though its trajectory is intact, the sector is not immune, however, to overarching economic factors like inflation, higher interest rates and tightening capital markets, which are impacting investors and life sciences companies looking to occupy space within a tight budget. Positioned for Continued Growth

Positioned for Continued Growth Real Estate Fundamentals Remain Strong

02

This 2022 Life Sciences Update breaks down the current trends in the life sciences industry by exploring: • Strength of the real estate fundamentals; • The ongoing labour crunch; • How the economic slowdown is impacting the industry; and • The continued flow of funding into life sciences. The report also contains a market-by market analysis, providing detailed overviews of key life sciences markets across the globe.

03

The Labour Crunch

06

The Impact of the Economic Slowdown

09

Flow of Funding

11

Future Demand

14

Market Summaries

17

United States

18

Canada

31

United Kingdom

35

Appendix

39

2 / CUSHMAN & WAKEFIELD

LIFE SCIENCES UPDATE | 2022 OCTOBER